Shibasaki Yasunobu | Division Of Cardiovascular Medicine Murakami Memorial Hospital Asahi University

スポンサーリンク

概要

関連著者

もっと見る

著作論文

IS104 Cell-specific Distribution of Angiotensin II Receptor Subtypes and Receptors-mediated Biochemical Changes in Failing Human Hearts
IS040 Angiotensin Type 2 (AT2) Receptor Inhibits AT1-mediated Intracelluar Alkalosis to Enhance Kinik Production in Vascular Smooth Muscle Cells From Vascular-targeted AT2 Transgenic Mice
OJ-261 Carperitide can Prevent Acute Renal Failure from Contrast-media in Patients with Moderate Chronic Kidney Disease(OJ44,Kidney/Renal Circulation/CKD 2 (H),Oral Presentation (Japanese),The 73rd Annual Scientific Meeting of The Japanese Circulation Soc
PJ-559 Human atrial natriuretic peptide (hANP) can prevent contrast-media nephropathy(Preventive medicine/Epidemiology/Education(07)(H),Poster Session(Japanese),The 72nd Annual Scientific Meeting of the Japanese Circulation Society)
PJ-147 The Predictive Factor and In-hospital Outcome of Contrast-Induced Nephropathy in patients undergoing emergency coronary stent implantation for acute coronary syndrome(Kidney/Renal circulation(05)(H),Poster Session(Japanese),The 72nd Annual Scientif
PJ-651 The Predictive Factor and In-hospital Outcome of Contrast-Induced Nephropathy in Patients Undergoing Emergency Coronary Stenting for Acute Coronary Syndrome(Kidney/Renal circulation-4, The 71st Annual Scientific Meeting of the Japanese Circulation
OJ-240 Effect of Sodium Bicarbonate for the Prevention of Contrast-Induced Nephropathy in Patients Undergoing Coronary Angiography(OJ40,Preventive Medicine/Epidemiology/Education (H),Oral Presentation (Japanese),The 73rd Annual Scientific Meeting of The J
PJ-560 Effect of Sodium Bicarbonate on the Prevention of Contrast Induced Nephropathy in Patients Undergoing Coronary Angiography(Preventive medicine/Epidemiology/Education(07)(H),Poster Session(Japanese),The 72nd Annual Scientific Meeting of the Japanese
PJ-653 Sodium Bicarbonate for Prevention of Contrast Induced Nephropathy in Patients with Diabetes Mellitus(Kidney/Renal circulation-4, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
PJ-422 Effect of Statin Therapy to Prevent In-stent Neointimal Proliferation after Coronary Stent Implantation; 3D-volumetric Intravascular Ultrasound Study(Restenosis, basic/clinical-5 (IHD) PJ71,Poster Session (Japanese),The 70th Anniversary Annual Scie
PJ-238 Contrast-induced Nephropathy in Patients Undergoing Emergency Coronary Angiography for Acute Coronary Syndrome(Kidney/Renal circulation-5 (H) PJ40,Poster Session (Japanese),The 70th Anniversary Annual Scientific Meeting of the Japanese Circulation
PJ-234 Effects of Pitavastatin and Eicosapentaenoic Acid on Platelet-Derived Microparticles And Adiponectin in Hyperlipidemic Patients with Type 2 Diabetes Mellitus(Atherosclerosis,clinical(10)(IHD),Poster Session(Japanese),The 72nd Annual Scientific Meet
PJ-639 Pitavastatin Increases Circulating Adiponectin in Hyperlipemic Patients(Atherosclerosis, clinical-13 (H) PJ107,Poster Session (Japanese),The 70th Anniversary Annual Scientific Meeting of the Japanese Circulation Society)
Augmented Angiogenesis in Ischemic Limbs in Transgenic Mice Overexpressing eNOS in Endothelium
Systemic Delivery of Bone Marrow Mononuclear Cells(BM-MNC) Accelerates Reendothelialization and Markedly Attenuates Intimal Hyperplasia in Balloon-Injured Carotid Artery
Nitric Oxide Blunts Sympathetic Nerve Activity in Patients with Left Ventricular Dysfunction
PJ-607 The Effects of Telmisartan in Patients with Metabolic Syndrome(Diabetes/Obesity/Metabolic syndrome-09, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
Effect of Statin Therapy on In-stent Neointimal Proliferation after Coronary Stent Implantation ; 3D-Volumetric Intravascular Ultrasound Study (Restenosis after Angioplasty, Basic/Clinical 6 (IHD), The 69th Annual Scientific Meeting of the Japanese Circul
Relationship between Effectiveness of Statin Therapy on In-stent Restenosis and Arterial Remodeling in Patients with Acute Coronary Syndrome ; 3D-IVUS Study(Coronary Revascularization, PTCA/Stent/DCA/Rotablator/New Device 2 (IHD), The 69th Annual Scientif
Is It Appropriate to Implant Additional Drug Eluting Stent in the Moderate Lesion of the Vessel Subjected to Coronary Intervention?(Coronary Revascularization, PTCA/Stent/DCA/Rotablator/New Device 1 (IHD), The 69th Annual Scientific Meeting of the Japanes
Intravenous Recombinant Tissue Plasminogen Activator (Rr-PA) Administration Prior to Thrombectomy Can Improve Coronary Perfusion in Patients with Acute Myocardial Infarction(Coronary Revascularization, PTCA/Stent/DCA/Rotablator/New Device 14 (IHD), The 69
Inflammation May Lead to the Development of Coronary Spasm
Differences in Indication of Coronary Angiography within Class I of ACC/AHA Guideline between Japan and USA
Preinterventional Coronary Artery Remodeling Influences In-Stent Restenosis : A 3D-Volumetric Intravascular Ultrasound Analysis
OJ-266 Bone Marrow Mononuclear Cells (BM-MNC) Implantation for the Patients with Advanced Coronary Artery Disease(Angiogenesis 2 (M) : OJ31)(Oral Presentation (Japanese))
Atorvastatin Prevents In-stent Restenosis after Coronary Stenting in Patients with Acute Coronary Syndrome(Coronary Revascularization, PTCA/Stent/DCA/Rotablator/New Device 2 (IHD), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
PJ-473 Suboptimal Glycemic Control Associates with Stent Restenosis after Coronary Stenting(Coronary Revascularization, PTCA/Stent/DCA/Rotablator/New Device 12 (IHD) : PJ79)(Poster Session (Japanese))
PE-142 Suitable Stent Size for Small Vessel of Proximal Left Anterior Descending Coronary Artery(Coronary Revascularization, PTCA/Stent/DCA/Rotablator/New Device 8 (IHD) : PE25)(Poster Session (English))
Effects of Intravenous Administration of Tissue Plasminogen Activator Before Thrombectomy in Patients With Acute Myocardial Infarction
OJ-459 Relationship between Arterial Remodeling and Effectiveness of Statin Therapy on In-stent Restenosis after Stenting in Patients with Acute Coronary Syndrome(Acute Coronary Syndrome, Basic/Clinical 5 (IHD) : OJ56)(Oral Presentation (Japanese))
OJ-380 Effect of Statin Therapy on Restenosis after Coronary Stenting in The Patients with Acute Coronary Syndrome Focusing on Positive Remodeling(Restenosis after Angioplasty, Basic/Clinical 3 (IHD) : OJ46)(Oral Presentation (Japanese))
Suboptimal Glycemic Control Associates with Diffuse In-Stent Restenosis after Coronary Stenting
Coronary spasm plays an important role in the development of atheroscrelotic coronary obstruction. : Long term angiographic follow-up results
Angiogenesis and Angiotensin II : Differential Postnatal Angiogenic Activities Unmasked by Gene-Engineered Mouse Models of Angiotensin AT1 and AT2 Receptor Subtypes
Impact of the Angiotensin II Receptor Antagonist, Losartan, on Myocardial Fibrosis in Patients with End-Stage Renal Disease : Assessment by Ultrasonic Integrated Backscatter and Biochemical Markers
Fluoroscopically Assisted Hybrid Thrombectomy : An Improved Method for Treating Acute Limb Ischemia(Peripheral Circulation/Vascular Disease 5 (H), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
Preventive Effect of Statin Treatment on In-Stent Restenosis after Primary Stenting for the Patient with Acute Myocardial Infarction
Safety and Availability of Doxazosin in Treating Hypertensive Patients with Chronic Renal Failure
Prevalence of coronary vasospasm in patients without significant coronary lesion who had class I indication for coronary angiography
Cryofiltration and Oral Corticosteroids Provide Successful Treatment for an Elderly Patient with Cryoglobulinemic Glomerulonephritis Associated with Hepatitis C Virus Infection
Statin Therapy Can Prevent In-Stent Restenosis (ISR) after Coronary Stenting in the Patient with Acute Coronary Syndrome (ACS)
Cigarette Smoking is the predictive factor for In-stent restenosis
Angiotensin II Receptor Type 1 Antagonist Suppress Cardiac Fibrosis in Patients with End Stage Renal Disease (ESRD)

もっと見る

スポンサーリンク